首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1539557

數位 PCR 市場規模、佔有率和成長分析：按產品、按最終用戶、按應用、按地區 - 行業預測，2024-2031 年

Digital PCR Market Size, Share, Growth Analysis, By Offerings, By End User, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月12日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球數位PCR市場規模將為68.3億美元，預測期內（2024-2031年）複合年成長率為9.02%，從2023年的85億美元增加到2031年的158億美元。美國6000萬美元。

由於對精確、靈敏的核酸定量和分析的需求不斷增加，全球數位 PCR（聚合酵素鏈鎖反應）市場正在經歷快速成長。數位PCR因其準確性和靈敏度而受到高度重視，已成為基因檢測、疾病診斷和研究中不可或缺的一部分。這個市場旨在為醫療保健專業人員、臨床實驗室和研究人員提供先進的分子診斷工具，提供準確可靠的結果，並最終增強患者照護和科學進步，這就是我的目標。有幾個因素正在推動市場擴張，包括遺傳性疾病和感染疾病的日益流行、對個人化醫療的需求不斷增加以及基因組研究的進步。但數位PCR設備也存在價格高、潛在使用者認知度低等問題。主要市場趨勢包括數位 PCR 與次世代定序儀技術的整合以及可同時檢測多個目標的多重數位 PCR 檢測的開拓。儘管存在這些挑戰，市場仍然存在巨大的成長機會。這是由於新興國家擴大採用數位 PCR、數位 PCR 在腫瘤學和感染疾病診斷中的作用不斷擴大，以及不斷採用功能增強的創新產品。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific（US）
Bio-Rad Laboratories（US）
QIAGEN（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Fluidigm Corporation（US）
Merck KGaA（Germany）
Agilent Technologies（US）
BioMerieux SA（France）
Takara Bio Inc.（Japan）
Danaher Corporation（US）
JN Medsys（Singapore）
Formulatrix, Inc.（US）
Stilla Technologies（France）
Becton, Dickinson and Company（US）
Sysmex Corporation（Japan）
Quantabio（US）
Illumina, Inc.（US）
Promega Corporation（US）
Eppendorf AG（Germany）
PerkinElmer, Inc.（US）
LGC Biosearch Technologies（UK）

簡介目錄

Product Code: SQMIG35G2206

Global Digital PCR Market size was valued at USD 6.83 Billion in 2022 and is poised to grow from USD 8.5 Billion in 2023 to USD 15.86 Billion by 2031, at a CAGR of 9.02 % during the forecast period (2024-2031).

The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth, driven by the rising need for precise and sensitive nucleic acid quantification and analysis. Digital PCR is highly valued for its accuracy and sensitivity, making it crucial for genetic testing, disease diagnosis, and research. The market aims to deliver advanced molecular diagnostic tools that provide healthcare professionals, clinical laboratories, and researchers with accurate and reliable results, ultimately enhancing patient care and scientific progress. Several factors propel the market's expansion, including the increasing incidence of genetic disorders and infectious diseases, the growing demand for personalized medicine, and advancements in genomic research. However, the market also contends with challenges such as the high cost of digital PCR equipment and limited awareness among potential users. Key market trends include the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays that allow for the simultaneous detection of multiple targets. Despite these challenges, the market offers substantial growth opportunities. This is driven by the rising adoption of digital PCR in emerging economies, its expanding role in oncology and infectious disease diagnostics, and the ongoing introduction of innovative products with enhanced capabilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Digital PCR market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital PCR Market Segmental Analysis

Global Digital PCR Market is segmented based on offering, end user, application, and region. Based on offering, the market is segmented into qPCR Offering [qPCR Products (qPCR Reagents and Consumables, qPCR Instruments), qPCR Software, dPCR Services], dPCR Offerings [dPCR Reagents and Consumables, dPCR Instruments (Droplet digital PCR, Chip-based digital PCR, Beaming digital PCR), dPCR Software, dPCR Services]. Based on end user, the market is segmented into qPCR End Users and dPCR End Users [Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, Other End Users]. Based on application, the market is segmented into Clinical Applications [Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, Other Clinical Applications], Research Applications [Single-cell analysis, Stem cell research, Gene expression, Others], Forensic Applications, Environmental Applications, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital PCR Market

Technological advancements in digital polymerase chain reaction (dPCR) are set to greatly impact market growth. These innovations represent a notable shift from traditional PCR methods, providing direct nucleic acid quantification and clonal amplification. The rising demand for state-of-the-art dPCR devices, alongside heightened research and development efforts, has led to the emergence of advanced PCR technologies that deliver significant advantages. This progress underscores the transformative potential of dPCR in improving molecular diagnostics and research outcomes.

Restraints in the Global Digital PCR Market

The uptake of digital PCR technology may be constrained by the significant initial costs involved in acquiring the necessary instruments and reagents. Digital PCR systems demand specialized equipment and consumables, which can be costly for research labs and smaller healthcare facilities. These high expenses might restrict access to digital PCR technology, particularly in resource-limited environments or for researchers operating with tight budgets.

Market Trends of the Global Digital PCR Market

Digital PCR and next-generation sequencing (NGS) technologies are complementary and can be integrated for a more comprehensive genomic analysis. By combining digital PCR's precise quantification capabilities with NGS's sequencing data, researchers gain access to both qualitative and quantitative insights. This integration enhances the identification of rare genetic variants, validates NGS findings, and allows for the detailed analysis of complex genomic changes associated with diseases.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Pricing Analysis
Patent Analysis
Trade Analysis
Technology Analysis
Supply Chain Analysis
Value Chain Analysis

Global Digital PCR Market by Offering

QPCR Offering
- QPCR Products
  - QPCR Reagents and Consumables
  - QPCR Instruments
- QPCR Software
- QPCR Services
DPCR Offering
- DPCR Reagents and Consumables
- DPCR Instruments
  - Droplet digital PCR
  - Chip-based digital PCR
  - Beaming digital PCR
- DPCR Software
- DPCR Services

Global Digital PCR Market by Application

QPCR & DPCR Application
- Clinical Applications
- Infectious Disease Testing
- Oncology Testing
- Blood Screening
- Transplant Diagnostics
- Others
- Research Applications
- Single-cell analysis
- Stem cell research
- Gene expression
- Others
- Forensic Applications
- Environmental Applications
- Others

Global Digital PCR Market by End-User

QPCR & DPCR End-User
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- CROs and CDMOs
- Forensic Laboratories
- Others

Global Digital PCR Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JN Medsys (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Formulatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stilla Technologies (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantabio (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Biosearch Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments